Monitor the December 22 special meeting outcome. If the proposal passes, the company will have capacity to issue up to 250 million additional shares, which could lead to future dilution. The repeated adjournments suggest management is still gathering sufficient votes.
OCGN drugs
OCGN drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $0.9721entry
- T+1 · 7d ago −2.27%α −1.91% · $0.9500
- T+5 · 20h ago −20.48%α −18.79% · $0.7730
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Ocugen filed a DEFA14A notice postponing its reconvened special meeting to December 22, 2026, to vote on a proposal to increase authorized common shares by 250 million. The meeting was originally convened on September 21, 2026, and has been adjourned multiple times. The board unanimously recommends a vote FOR the proposal.
Key Financial Metrics
Key Facts
- Special meeting reconvened on December 22, 2026 at 8:00 a.m. ET.
- Proposal 1: increase authorized common shares by 250,000,000 shares.
- Board unanimously recommends a vote FOR Proposal 1.
- New record date is October 30, 2026; 339,306,603 shares outstanding as of that date.
- Adjournment Proposal already approved by stockholders on September 21, 2026.
- Proxy solicitor: Campaign Management.
Financial Impact
Authorized share increase of 250 million shares; current outstanding shares 339,306,603 as of October 30, 2026.
Risk Factors
- Potential dilution if the share increase is approved and subsequently used for capital raises or acquisitions.
- Repeated meeting adjournments may indicate shareholder resistance to the proposal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-042515 |
| Document: 0001140361-26-042515-index-headers.html | 0001140361-26-042515 |
| Document: 0001140361-26-042515-index.html | 0001140361-26-042515 |
| Document: 0001140361-26-042515.txt | 0001140361-26-042515 |
Track record
23 reports on OCGN
3 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +20.49% at T+20 after the Jun 11, 2026 report. 4 of 6 went positive at some point.
Filters
- Nov 10, 20266d ago 8-K Neutral 4/10 Entry $0.9500 to $0.9604 Now $0.7730 −18.63% ▲ +1.09% −0.22% vs SPY
- Nov 10, 20266d ago Press Release Neutral 4/10 Entry $0.9500 to $0.9604 Now $0.7730 −18.63% ▲ +1.09% −0.22% vs SPY
- Nov 6, 202610d ago DEFA14A Neutral 2/10 Entry $0.9721 to $0.9500 Now $0.7730 −20.48% ▼ −2.27% −1.91% vs SPY
- Nov 6, 202610d ago DEFA14A Neutral 3/10 Viewing Entry $0.9721 to $0.9500 Now $0.7730 −20.48% ▼ −2.27% −1.91% vs SPY
- Nov 4, 202612d ago 8-K Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $0.8745 to $0.8165 Now $0.7730 −11.61% ▼ −6.63% −2.22% vs SPY
- Oct 15, 20264w ago 8-K Neutral 5/10 Entry $0.8137 to $0.7803 Now $0.7730 −5.00% ▼ −4.10% −3.00% vs SPY
- Oct 14, 20264w ago 8-K Mixed 5/10 Entry $0.8137 to $0.7803 Now $0.7730 −5.00% ▼ −4.10% −3.00% vs SPY
- Oct 9, 20265w ago 144 Neutral 2/10 Entry $0.9472 to $0.8854 Now $0.7730 −18.39% ▼ −6.52% −6.51% vs SPY
- Sep 1, 202610w ago Press Release Bullish 7/10 Entry $1.33 to $1.32 Now $0.7730 −41.88% ▼ −0.75% −1.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers